Oral antidiabetic agents in pregnancy and lactation: A paradigm shift?

Medicine and Dentistry

• Lactation 100%
• Oral Antidiabetic Agent 100%
• Glycon 100%
• Glibenclamide 100%
• Glipizide 100%
• Gestational Diabetes 66%
• Breast Feeding 33%
• Randomized Controlled Trial 33%
• Metformin Plus Rosiglitazone 33%
• Developmental Toxicity 33%
• Glibenclamide Plus Metformin 33%
• Polycystic Ovarian Syndrome 33%
• Placenta 16%
• Clinical Trial 16%
• Cohort Analysis 16%
• Third Trimester Pregnancy 16%
• Antidiabetic Agent 16%
• Human Milk 16%
• Controlled Clinical Trial 16%
• Polycystic Ovary Syndrome 16%
• Rosiglitazone 16%
• Thiazolidinedione 16%
• Pioglitazone 16%
• Patient with Type 2 Diabetes 16%
• Case-Control Study 16%

Keyphrases

• Lactation 100%
• Metformin 100%
• Oral Antidiabetic Agents 100%
• Glyburide 88%
• Glipizide 66%
• Gestational Diabetes 33%
• Polycystic Ovary Syndrome 33%
• Rosiglitazone 33%
• Breast 22%
• Randomized Controlled Trial 22%
• Developmental Toxicity 22%
• Controlled Experiment 11%
• Placenta 11%
• Clinical Trials 11%
• Diabetic Pregnancy 11%
• Third Trimester 11%
• MEDLINE 11%
• Teratogenic 11%
• Breast Milk 11%
• Data Extraction 11%
• Type 2 Diabetic Patients 11%
• Pioglitazone 11%
• Hypoglycemic Activity 11%
• Pregnancy in Diabetics 11%
• MeSH Headings 11%
• Human Information 11%
• Thiazolidinediones 11%
• Methodological Challenges 11%
• Glucose Control 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Glibenclamide 100%
• Metformin 100%
• Oral Antidiabetic Agent 100%
• Glipizide 100%
• Pregnancy Diabetes Mellitus 66%
• Syndrome 33%
• Randomized Controlled Trial 33%
• Glibenclamide Plus Metformin 33%
• Metformin Plus Rosiglitazone 33%
• Developmental Toxicity 33%
• Cohort Study 16%
• Antidiabetic Agent 16%
• Clinical Trial 16%
• Case-Control Study 16%
• Controlled Clinical Trial 16%
• Ovary Polycystic Disease 16%
• Pioglitazone 16%
• Rosiglitazone 16%
• Thiazolidinedione 16%
• Non Insulin Dependent Diabetes Mellitus 16%